Janssen Strengthens Sporanox Liver Toxicity Warning; Expands Monitoring
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Revised labeling for Johnson & Johnson’s antifungal Sporanox (itraconazole) expands the recommendation for liver function monitoring to include all patients.